DS

Digvijay Singh

Director DIN 06767079
DIN 06767079 First appointment Feb 2014
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Digvijay Singh

Data last updated:

Digvijay Singh was a Director at Acute International Private Limited (from 2014) and Director at Doffin Pharmaceuticals Private Limited (from 2015).

DIN 06767079
First Appointment 26 Feb 2014
Oldest Company Age 12 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Acute International Private Limited U74999DL2014PTC265483
Director26 Feb 20142014Strike Off
Director08 Sep 20152015Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Acute International Private Limited
Doffin Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Digvijay Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Digvijay Singh

Digvijay Singh was first appointed on 26 Feb 2014 as Director at Acute International Private Limited. The most recent appointment on record is 08 Sep 2015 at Doffin Pharmaceuticals Private Limited.

Digvijay Singh held 2 earlier board appointments: Acute International Private Limited (Director, from 26 Feb 2014); Doffin Pharmaceuticals Private Limited (Director, from 08 Sep 2015).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available